Sugimoto Mikio

スギモトミキオ | Sugimoto Mikio

Affiliation and department：
Job title： Associate Professor

Research field (1)： Urology

Research keywords (3)： rare sugar , 泌尿器科悪性腫瘍 , urological oncology

Research theme for competitive and other funds (24)：

2023 - 2027 解決構築度尺度を用いた生体腎ドナーのHRQOL低下予防法の開発
2023 - 2026 慢性前立腺炎の新規診断支援ツールの開発
2022 - 2025 薬剤耐性腫瘍に対する標的分子抑制ベクターによる遺伝子治療の開発
2020 - 2023 Development of a novel treatment strategy for renal cell carcinoma using the rare sugar D-allose: Elucidation of the antitumor mechanism.
2018 - 2021 Quantitative bone evaluation to monitor in castration-resistant prostate cancer bone metastases

2017 - 2020 Establishment of active surveillance program involved by mpMRI for early prostate cancer

2016 - 2019 The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Bladder Cancer.

2014 - 2017 Comprehensive analysis of cytokine and chemokine in prostatic hypertrophy with non-bacterial chronic inflammation

2013 - 2016 Anti-proliferative activity of Adenoviral vector expressing short hairpin RNA targeting G-Protein coupled receptor (GPR87) in urothelial carcinoma

2012 - 2015 Study on the usefulness of p2PSA as a predictor of clinical progression in prostate cancer patients undergoing active surveillance

2012 - 2015 Development of lexatumumab in combination with temsirolimus against advanced renal cell carcinoma

2011 - 2013 Development of detecting circulating renal cancer cells that have Death Receptor 5 as a surface marker

2009 - 2011 Uroplakin III-delta 4 as a new molecular marker for interstitial cystitis

2008 - 2010 Development of anti-TRAIL receptor antibod y in combination with chemotherapeutic therapy against advanced genitourinary cancers : expansion of animal model

2010 - 早期前立腺癌に対する(PSA)監視療法

2010 - Active surveillance for early prostate cancer

2009 - 前立腺肥大症の成因としての慢性前立腺炎症

2009 - Relationship between chronic prostatitis and benign prostatic hypertrophy

1997 - 1997 腎孟膀胱外シャントカテーテルの開発

1993 - 1994 SPERM MATURATION AND THE FUNCTION SERTORI CELL

1993 - 1993 精巣のCa-カルモデュリン依存性脱リン酸化酵素カルシニューリン

1992 - 1993 Clinical and experimental studies of bone metastasis in prostatic cancer

前立腺癌予後予測因子としての新規マーカーの研究

new predictive biomarker of prostate cancer

Show all

Papers (251)：

Rikiya Taoka, Hideo Fukuhara, Makito Miyake, Keita Kobayashi, Atsushi Ikeda, Kent Kanao, Yoshinobu Komai, Ryo Fujiwara, Yusuke Sato, Mikio Sugimoto, et al. Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial. International journal of clinical oncology. 2024
Takuma Kato, Ryuji Matsumoto, Akira Yokomizo, Yoichiro Tohi, Hiroshi Fukuhara, Yoichi Fujii, Keiichiro Mori, Takuma Sato, Junichi Inokuchi, Katsuyoshi Hashine, et al. Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN). BJU international. 2024
Rikiya Taoka, Masaki Kamada, Kazuyoshi Izumi, Ryuta Tanimoto, Kei Daizumoto, Yushi Hayashida, Katsutoshi Uematsu, Hironobu Arai, Takeshi Sano, Ryoichi Saito, et al. Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study. International journal of clinical oncology. 2024. 29. 5. 602-611
田岡利宜也, 鎌田正紀, 泉和良, 谷本竜太, 林田有史, 大豆本圭, 上松克利, 齊藤亮一, 杉元幹史. 進行尿路上皮癌に対するエンホルツマブ・ベドチンの治療アウトカムおよび末梢神経の電気生理変化多機関共同前向き観察研究. 西日本泌尿器科学会総会抄録集. 2023. 75回. 215-215
Yoichiro Tohi, Takuma Kato, Keita Kobayashi, Kei Daizumoto, Hideo Fukuhara, Shin Ohira, Satoshi Katayama, Ryutaro Shimizu, Atsushi Takamoto, Kenichi Nishimura, et al. Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological Consortium. Japanese journal of clinical oncology. 2023

ｍore...

MISC (569)：

倉石佳奈, 紺谷桂一, 橋本新一郎, 法村尚子, 本城尚美, 大谷昌裕, 上田修史, 伊達学, 杉元幹史, 横見瀬裕保. 腎カルチノイド乳房転移の1例. 乳癌の臨床. 2022. 37. 1. 107-114
上村博司, 大家基嗣, 賀本敏行, 杉元幹史, 野々村祝夫, 篠崎健太, 森田聖美, 高橋真生, 新居正弘, 古藤諒, et al. リアルワールドにおける転移性去勢抵抗性前立腺癌患者の相同組換え修復関連遺伝子変異保有率及び予後に関する国内多施設共同観察研究 ZENSHIN Study. 日本泌尿器科学会総会. 2021. 109回. LB02-04
田岡利宜也, 松岡祐貴, 山崎真理, 松田伊織, 藤原健悟, 原田怜, 伊藤文子, 土肥洋一郎, 宮内康行, 加藤琢磨, et al. PDD-TURBTの短期治療アウトカム筋層非浸潤性膀胱癌の完全切除・再発抑制効果. 日本泌尿器科学会総会. 2021. 109回. OP45-04
山崎真理, 田岡利宜也, 片倉和哉, 伊藤文子, 土肥洋一郎, 宮内康行, 松岡祐貴, 加藤琢磨, 常森寛行, 上田修史, et al. 国際尿細胞診報告様式パリシステムの診断予測能評価. 日本泌尿器科学会総会. 2021. 109回. OP84-07
松岡祐貴, 田岡利宜也, 土肥洋一郎, 張霞, 杉元幹史. 膀胱癌細胞においてCl-チャネルブロッカーは蒸留水が誘導する殺細胞効果を増強する. 日本泌尿器科学会総会. 2021. 109回. PP27-05

ｍore...

Lectures and oral presentations (36)：

合併症・QOLからみた各種限局がん治療の比較
(第34回前立腺シンポジウム 2018)
~mHNPCの“標準治療”を考える~
(Update on Prostate Cancer 2018 2018)
Invited lecture Should inclusion criteria for AS be more stringent? -From the interim analysis of PRIAS-JAPAN-
(34th Korea-Japan Urological Congress 2017)
Plenary session Optimal Use of Novel Biomarkers and Detection Strategies for Bladder Cancer Panelist:Practical Application of New Therapies and Diagnosis in Bladder Cancer:Cases and Q&A
(SIU 2016)
Urology in Asia Symposium SessionI:Prostate Cacer:panelist
(SIU 2016)

ｍore...

Education (4)：

- 1992 Kagawa Medical University 医学研究科生体制御系
- 1992 Kagawa Medical University
- 1988 Kagawa Medical University Faculty of Medicine 医学科
- 1988 Kagawa Medical University

Professional career (1)：

博士(医学) (Kagawa University)

Work history (9)：

2018/07 - 現在香川大学医学部泌尿器科教授
2007 - 2018/06 - 香川大学医学部, 准教授
2006 - 2007 Kagawa University University Hospital, Faculty of Medicine
1997 - 2005 総合病院坂出市立病院, 泌尿器科・医長
2005 - 総合病院坂出市立病院, 泌尿器科・医長診療部長兼務

Show all

Awards (1)：

2015/10 - 第35回日本癌治療学会学術集会優秀演題賞

Association Membership(s) (9)：

日本癌学会 , 臨床腫瘍学会 , 日本内視鏡外科学会 , 日本排尿機能学会 , 米国泌尿器科学会 , 日本透析医学会 , 日本癌治療学会 , 日本泌尿器科学会 , 日本Endourology-ESWL学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page